Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Arrowhead Announces Inducement Grants Under NASDAQ Rule 5635(c)(4)



  Arrowhead Announces Inducement Grants Under NASDAQ Rule 5635(c)(4)

Business Wire

PASADENA, Calif. -- October 25, 2013

Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company
developing targeted RNAi therapeutics, today announced it awarded "inducement"
options to two new employees under Rule 5635(c)(4) of the NASDAQ Marketplace
Rules as an inducement for entering into employment with the Company. The
options entitle the employees to purchase, outside of the Company's
stockholder approved equity incentive plans, an aggregate of up to 105,000
shares of the Company's common stock at an exercise price per share of $7.98,
the last reported closing price of the Company's common stock on the date of
grants. The options vest and become exercisable over a period of four years
from the date of grant.

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing
targeted RNAi therapeutics. The company is leveraging its proprietary drug
delivery technologies to develop targeted drugs based on the RNA interference
mechanism that efficiently silence disease-causing genes. Arrowhead
technologies also enable partners to create peptide-drug conjugates that
specifically home to cell types of interest while sparing off-target tissues.
Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus
and obesity and partner-based programs in oncology.

For more information please visit http://www.arrowheadresearch.com, or follow
us on Twitter @ArrowRes. To be added to the Company's email list to receive
news directly, please send an email to ir@arrowres.com.

Contact:

Arrowhead Research Corporation
Vince Anzalone, CFA
626-304-3400
or
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement